Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Dec 12:8:1045.
doi: 10.3389/fphys.2017.01045. eCollection 2017.

The Role of Inflammation in Age-Related Sarcopenia

Affiliations
Review

The Role of Inflammation in Age-Related Sarcopenia

Sebastiaan Dalle et al. Front Physiol. .

Abstract

Many physiological changes occur with aging. These changes often, directly or indirectly, result in a deterioration of the quality of life and even in a shortening of life expectancy. Besides increased levels of reactive oxygen species, DNA damage and cell apoptosis, another important factor affecting the aging process involves a systemic chronic low-grade inflammation. This condition has already been shown to be interrelated with several (sub)clinical conditions, such as insulin resistance, atherosclerosis and Alzheimer's disease. Recent evidence, however, shows that chronic low-grade inflammation also contributes to the loss of muscle mass, strength and functionality, referred to as sarcopenia, as it affects both muscle protein breakdown and synthesis through several signaling pathways. Classic interventions to counteract age-related muscle wasting mainly focus on resistance training and/or protein supplementation to overcome the anabolic inflexibility from which elderly suffer. Although the elderly benefit from these classic interventions, the therapeutic potential of anti-inflammatory strategies is of great interest, as these might add up to/support the anabolic effect of resistance exercise and/or protein supplementation. In this review, the molecular interaction between inflammation, anabolic sensitivity and muscle protein metabolism in sarcopenic elderly will be addressed.

Keywords: NSAID; inflammation; muscle protein metabolism; muscle wasting; protein supplementation; resistance training; sarcopenia.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Schematic illustration of the mechanisms through which LGI may indirectly affect age-related muscle wasting. LGI, low-grade inflammation; AA, amino acid; AT, adipose tissue; MPS, muscle protein synthesis, MPB, muscle protein breakdown. Red lines contribute to the induction of muscle wasting; green lines to the attenuation of muscle wasting. Dashed lines: inhibitory signaling; full lines: stimulatory signaling. Additional to the association between LGI and age-related muscle wasting, the beneficial effects of classic strategies such as exercise and protein supplementation are illustrated.

References

    1. Abdulla H., Smith K., Atherton P. J., Idris I. (2016). Role of insulin in the regulation of human skeletal muscle protein synthesis and breakdown : a systematic review and meta-analysis. Diabetologia 59, 44–55. 10.1007/s00125-015-3751-0 - DOI - PubMed
    1. Allaire J., Couture P., Leclerc M., Charest A., Marin J., Marie-claude L., et al. . (2016). A randomized, crossover, head-to-head comparison of eicosapentaenoic acid and docosahexaenoic acid supplementation to reduce inflammation markers in men and women : the comparing EPA to DHA (ComparED) study. Am. J. Clin. Nutr. 104, 280–287. 10.3945/ajcn.116.131896 - DOI - PubMed
    1. Altun M., Besche H. C., Overkleeft H. S., Piccirillo R., Edelmann M. J., Kessler B. M., et al. . (2010). Muscle wasting in aged, sarcopenic rats is associated with enhanced activity of the ubiquitin proteasome pathway. J. Biol. Chem. 285, 39597–39608. 10.1074/jbc.M110.129718 - DOI - PMC - PubMed
    1. Andersson D. C., Betzenhauser M. J., Reiken S., Meli A. C., Umanskaya A., Xie W., et al. . (2011). Ryanodine receptor oxidation causes intracellular calcium leak and muscle weakness in aging. Cell Metab. 14, 196–207. 10.1016/j.cmet.2011.05.014 - DOI - PMC - PubMed
    1. Argilés J. M., Busquets S., Stemmler B., López-Soriano F. J. (2015). Cachexia and sarcopenia: mechanisms and potential targets for intervention. Curr. Opin. Pharmacol. 22, 100–106. 10.1016/j.coph.2015.04.003 - DOI - PubMed